Prof. Marc Wilkins
In 1994, Marc Wilkins developed the concept of the proteome and coined the term. He has since published >220 peer-reviewed research papers, review papers and book chapters in the fields of proteomics, genomics / transcriptomics and in systems biology. In proteomics, he has a focus on the functional analysis and regulation of protein methylation.
In industry, Wilkins has co-founded two biotechnology companies. Proteome Systems Ltd, established in 1999, developed proteomics technology and a platform for rapid point-of-care diagnostic testing. Regeneus Pty Ltd, established in 2007, has pioneered the clinical use of adult stem cells to treat a range of musculoskeletal disorders.
Wilkins has been elected to the council of HUPO four times, is a current council member, and was program chair of HUPO2010 (Sydney) and a co-organiser of HUPO2019 (Adelaide). He serves on of the management committee of the Australian Proteomics Society and is a co-organiser of its annual conference.